Prothena and the AFFIRM-AL Study: Ansgar Conrad – ASG Webinar 9/13

Amyloidosis Support Groups’ webinar for light chain (AL) amyloidosis was hosted on January 15, 2022. Led by ASG President Muriel Finkel, this webinar discusses the current treatments for light chain amyloidosis and features amyloidosis expert: Ansgar Conrad, PhD, VP, Medical Affairs & Patient Advocacy, Prothena Biosciences, Inc., South San Francisco, CA